FDA Warning and Removal of Rosiglitazone From VA National Formulary
September 19th 2013After the FDA warning and removal of rosiglitazone from the VA National Formulary, glucose control may have declined among those discontinuing rosiglitazone without receiving replacement medication.
Out-of-Pocket Costs and Prescription Reversals With Oral Linezolid
September 18th 2013Associations between out-of-pocket costs and prescription reversals, as well as impact of reversals on rehospitalizations and healthcare costs, were examined among patients prescribed oral linezolid.
Referring Patients for Telephone Counseling to Promote Colorectal Cancer Screening
September 16th 2013In this pilot study, primary care providers refer patients to a telephone counselor who provides education about colorectal cancer screening and performs motivational interviewing as needed to promote screening.
Testimonials Do Not Convert Patients From Brand to Generic Medication
September 11th 2013We conducted a randomized controlled trial to assess whether adding a peer testimonial to a mailing increases conversion rates from brand name prescription medications to lower-cost equivalents.
Improving Pneumococcal and Herpes Zoster Vaccination Uptake: Expanding Pharmacist Privileges
September 11th 2013States offering pharmacists full immunization privileges have significantly higher vaccination uptake rates for pneumococcal disease and herpes zoster than states with restricted or no authorization.